Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone (Q46732081)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone
scientific article

    Statements

    Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit